Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates have been created using our next-generation adenosine drug development platform, which enable design of patented compounds with favorable physiochemical characteristics and distribution kinetics that historically limited drugs acting against the adenosine receptors.

Biotechnology

Life Sciences

Pharmaceutical

Adovate

Adovate's headquarters in Charlottesville, United States

Description

People (4)

William Stilley

Joel Linden

Robert D. Thompson

Schuyler V.

Jobs